loadpatents
Patent applications and USPTO patent grants for Christopher; John Andrew.The latest application filed is for "cgrp antagonist compounds".
Patent | Date |
---|---|
Cgrp Antagonist Compounds App 20220306651 - Brown; Giles Albert ;   et al. | 2022-09-29 |
Oxexin 1 Receptor Antagonists App 20220098165 - Brown; Giles Albert ;   et al. | 2022-03-31 |
4-(3-cyanophenyl)-6-pyridinylpyrimidine Mglu5 Modulators App 20220056009 - CHRISTOPHER; John Andrew ;   et al. | 2022-02-24 |
Orexin 1 Receptor Antagonists App 20220041573 - Brown; Giles Albert ;   et al. | 2022-02-10 |
4-(3-cyanophenyl)-6-pyridinylpyrimidine Mglu5 Modulators App 20210309632 - Christopher; John Andrew ;   et al. | 2021-10-07 |
Cgrp Receptor Antagonists App 20210213011 - Christopher; John Andrew ;   et al. | 2021-07-15 |
Ox1 Antagonists App 20210179578 - Christopher; John Andrew ;   et al. | 2021-06-17 |
4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators Grant 10,981,889 - Christopher , et al. April 20, 2 | 2021-04-20 |
CGRP receptor antagonists Grant 10,888,561 - Christopher , et al. January 12, 2 | 2021-01-12 |
4-(3-cyanophenyl)-6-pyridinylpyrimidine Mglu5 Modulators App 20200172505 - Christopher; John Andrew ;   et al. | 2020-06-04 |
4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators Grant 10,584,111 - Christopher , et al. | 2020-03-10 |
Cgrp Receptor Antagonists App 20190231773 - Christopher; John Andrew ;   et al. | 2019-08-01 |
4-(3-cyanophenyl)-6-pyridinylpyrimidine Mglu5 Modulators App 20190177297 - Christopher; John Andrew ;   et al. | 2019-06-13 |
Orexin receptor antagonists Grant 10,316,028 - Congreve , et al. | 2019-06-11 |
CGRP receptor antagonists Grant 10,300,056 - Christopher , et al. | 2019-05-28 |
CGRP receptor antagonists Grant 10,259,812 - Christopher , et al. | 2019-04-16 |
4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators Grant 10,246,432 - Christopher , et al. | 2019-04-02 |
CGRP receptor antagonists Grant 10,166,226 - Christopher , et al. J | 2019-01-01 |
Orexin Receptor Antagonists App 20180370961 - Congreve; Miles Stuart ;   et al. | 2018-12-27 |
CGRP Receptor Antagonists App 20180153876 - Christopher; John Andrew ;   et al. | 2018-06-07 |
CGRP receptor antagonists Grant 9,925,178 - Christopher , et al. March 27, 2 | 2018-03-27 |
CGRP Receptor Antagonists App 20180015085 - Christopher; John Andrew ;   et al. | 2018-01-18 |
CGRP Receptor Antagonists App 20180009808 - Christopher; John Andrew ;   et al. | 2018-01-11 |
Orexin receptor antagonists Grant 9,850,237 - Congreve , et al. December 26, 2 | 2017-12-26 |
CGRP receptor antagonists Grant 9,808,457 - Christopher , et al. November 7, 2 | 2017-11-07 |
CGRP receptor antagonists Grant 9,802,935 - Christopher , et al. October 31, 2 | 2017-10-31 |
4-(3-cyanophenyl)-6-pyridinylpyrimidine Mglu5 Modulators App 20170275265 - Christopher; John Andrew ;   et al. | 2017-09-28 |
CGRP Receptor Antagonists App 20170239236 - Christopher; John Andrew ;   et al. | 2017-08-24 |
CGRP receptor antagonists Grant 9,688,660 - Christopher , et al. June 27, 2 | 2017-06-27 |
4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators Grant 9,676,745 - Christopher , et al. June 13, 2 | 2017-06-13 |
CGRP Receptor Antagonists App 20170121331 - Christopher; John Andrew ;   et al. | 2017-05-04 |
Cgrp Receptor Antagonists App 20170121311 - Christopher; John Andrew ;   et al. | 2017-05-04 |
Orexin Receptor Antagonists App 20170121320 - Congreve; Miles Stuart ;   et al. | 2017-05-04 |
CGRP Receptor Antagonists App 20170121348 - Christopher; John Andrew ;   et al. | 2017-05-04 |
Orexin receptor antagonists Grant 9,555,044 - Congreve , et al. January 31, 2 | 2017-01-31 |
Orexin Receptor Antagonists App 20160213678 - Congreve; Miles Stuart ;   et al. | 2016-07-28 |
4-(3-cyanophenyl)-6-pyridinylpyrimidine Mglu5 Modulators App 20160145236 - Christopher; John Andrew ;   et al. | 2016-05-26 |
Orexin receptor antagonists Grant 9,249,160 - Congreve , et al. February 2, 2 | 2016-02-02 |
Orexin Receptor Antagonists App 20150126498 - Congreve; Miles Stuart ;   et al. | 2015-05-07 |
Indole Derivatives and Use Thereof as Kinase Inhibitors in Particular Ikk2 Inhibitors App 20080269200 - Baldwin; Ian Robert ;   et al. | 2008-10-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.